Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China.
暂无分享,去创建一个
Gang Yu | Jun Huang | Shubo Deng | Gang Yu | Jun Huang | S. Deng | Q. Sui | Qian Sui | Qing Fan | Qing Fan
[1] Frank Sacher,et al. Removal of pharmaceuticals during drinking water treatment. , 2002, Environmental science & technology.
[2] A Joss,et al. Are we about to upgrade wastewater treatment for removing organic micropollutants? , 2008, Water science and technology : a journal of the International Association on Water Pollution Research.
[3] J. Santos,et al. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). , 2007, Environment international.
[4] A. Schäfer,et al. Occurrence of pharmaceutically active and non-steroidal estrogenic compounds in three different wastewater recycling schemes in Australia. , 2007, Chemosphere.
[5] Marianne Nyström,et al. Drawbacks of applying nanofiltration and how to avoid them: A review , 2008 .
[6] Jaeweon Cho,et al. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. , 2007, Water research.
[7] Shane A. Snyder,et al. Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products , 2006 .
[8] G. Huschek,et al. Environmental risk assessment of medicinal products for human use according to European Commission recommendations , 2004, Environmental toxicology.
[9] T. Tuhkanen,et al. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. , 2005, Water research.
[10] T. Tuhkanen,et al. Elimination of pharmaceuticals in sewage treatment plants in Finland. , 2007, Water research.
[11] D. Bagley,et al. The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound and water matrix properties , 2008 .
[12] Gun-Young Park,et al. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. , 2003, Environmental science & technology.
[13] A. Pollio,et al. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. , 2003, Ecotoxicology and environmental safety.
[14] Menachem Elimelech,et al. Pharmaceutical retention mechanisms by nanofiltration membranes. , 2005, Environmental science & technology.
[15] T. Tuhkanen,et al. Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. , 2007, Environmental science & technology.
[16] T. Ternes,et al. Ozonation of carbamazepine in drinking water: identification and kinetic study of major oxidation products. , 2005, Environmental science & technology.
[17] Kurtis Sarafin,et al. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. , 2006, The Science of the total environment.
[18] S. Bolton,et al. Caffeine: Psychological effects, use and abuse. , 1981 .
[19] Richard M. Dinsdale,et al. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. , 2009, Water research.
[20] K. Thomas,et al. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. , 2008, Ecotoxicology and environmental safety.
[21] Shane Snyder,et al. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. , 2005, Environmental science & technology.
[22] A. Takagi,et al. No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug. , 2005, Biological & pharmaceutical bulletin.
[23] W. Ding,et al. Using liquid chromatography-ion trap mass spectrometry to determine pharmaceutical residues in Taiwanese rivers and wastewaters. , 2008, Chemosphere.
[24] T Wintgens,et al. Removal of hormones and pharmaceuticals in the Advanced Water Recycling Demonstration Plant in Queensland, Australia. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.
[25] D. Calamari,et al. Removal of pharmaceuticals in sewage treatment plants in Italy. , 2006, Environmental science & technology.
[26] N. Paxéus. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.
[27] Stuart J Khan,et al. Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations. , 2004, Chemosphere.
[28] Adriano Joss,et al. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. , 2005, Environmental science & technology.
[29] Brett J. Vanderford,et al. Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. , 2006, Environmental science & technology.
[30] Gang Yu,et al. Rapid determination of pharmaceuticals from multiple therapeutic classes in wastewater by solid-phase extraction and ultra-performance liquid chromatography tandem mass spectrometry , 2009 .
[31] Martin Kampmann,et al. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? , 2003, Water research.
[32] Hideshige Takada,et al. Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. , 2007, Water research.
[33] H. Takada,et al. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. , 2006, Water research.
[34] P. Jjemba. Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. , 2006, Ecotoxicology and environmental safety.
[35] T. Ternes. Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .
[36] Oliver A.H. Jones,et al. The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. , 2007, Environmental pollution.
[37] Adriano Joss,et al. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. , 2007, The Science of the total environment.
[38] Jun Li,et al. Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. , 2007, Water research.
[39] B. Quinn,et al. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata. , 2008, The Science of the total environment.
[40] A. Fernández-Alba,et al. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. , 2007, Chemosphere.
[41] S. Costanzo,et al. Removal of antibiotics in conventional and advanced wastewater treatment: implications for environmental discharge and wastewater recycling. , 2007, Water research.
[42] Oliver A.H. Jones,et al. Human Pharmaceuticals in Wastewater Treatment Processes , 2005 .
[43] T. Murakami,et al. Comparison of natural estrogen removal efficiency in the conventional activated sludge process and the oxidation ditch process. , 2007, Water research.
[44] T. Ternes,et al. Pharmaceuticals and personal care products in the environment: agents of subtle change? , 1999, Environmental health perspectives.
[45] Christopher Bellona,et al. Rejection of wastewater‐derived micropollutants in high‐pressure membrane applications leading to indirect potable reuse , 2005 .
[46] F. Ventura,et al. Occurrence of psychoactive stimulatory drugs in wastewaters in north-eastern Spain. , 2008, The Science of the total environment.
[47] Long D. Nghiem,et al. NF/RO filtration of the hydrophobic ionogenic compound triclosan : Transport mechanisms and the influence of membrane fouling , 2008 .
[48] K. Kimura,et al. Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes , 2004 .
[49] N Yamashita,et al. Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China. , 2008, Water research.
[50] D. Barceló,et al. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. , 2008, Water research.
[51] G. Foster,et al. Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process , 2005, Environmental toxicology and chemistry.
[52] S. Fujii,et al. Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan. , 2008, Water science and technology : a journal of the International Association on Water Pollution Research.